ALSPW Spineway SAS

Reverse stock split

Reverse stock split

Press release        Ecully, February 29, 2024 – 6:00 p.m.



Effective date of the Spineway reverse stock split

Spineway announces the completion of the reverse stock split by exchanging 1 new share of 4.00 euros par value for 2,000 old shares of 0.002 euro par value. This transaction, which was carried out pursuant to a decision by the Company's shareholders at an Extraordinary General Meeting held on November 10, 2023, took effect on February 27, 2024.

The old Spineway shares with a par value of €0.002 (ISIN code: FR001400BVK2) were delisted from the Euronext Growth market after the close of the market on February 26, 2024 and were replaced with the new Spineway shares with a par value of €4.00 (ISIN code: FR001400N2P2) on February 27, 2024. The mnemonic code (ALSPW) remains unchanged.

As at 27 February 2024, Spineway's share capital comprised 832,962 shares with a par value of €4.00 each.

It should be noted that, as of February 26, 2024, after the close of the market, the new shares that could not be allotted individually and which correspond to fractional rights will be sold automatically by block on the market by financial intermediaries. The financial intermediaries will make the proceeds of the sale available to their shareholder clients within 30 days from February 26, 2024. For more information on the reverse split, shareholders are invited to consult the notice of reverse split published in the , and available on the Company's website () and the press release published on also available on the Company's website.

Increase in share capital

Following conversions of Negma Group Ltd bonds between 22 January 2024 and 9 February 2024, the Company's Board of Directors, meeting on 29 February 2024, recorded the creation of 1,191,228,073 new ordinary shares and an increase in the share capital of a nominal amount of €2,382,456.15. As these conversions took place during the consolidation period, the new shares issued were taken into account in the exchange transactions.

Reduction of the share capital

Subsequent to the reverse stock split, the Company's Board of Directors decided on 29 February 2024 to reduce the share capital by reducing the par value of the Company's shares1. This purely technical operation has no impact on the value of the Company's stock value, nor on the number of shares in circulation. Thus, after this operation, the Company's share capital is still composed of 832,962 ordinary shares, i.e. the number of shares making up the share capital following the above-mentioned reverse stock split, effective since 27 February 2024.

Next events:

March 25, 2024 – Annual General Meeting

April 16, 2024 – Q1 2024 revenue

SPINEWAY IS ELIGIBLE FOR PEA-SME (EQUITY SAVINGS PLANS FOR SMES)

Find out all about Spineway at

This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.

Contacts :

SPINEWAY GROUP



Shareholder - services line



Available Tuesday through Thursday



+33 (0)806 70 60 60
ELIGIBLE PEA / PME





ALSPW





Euronext Growth

AELIUM



Finance & Communication







Investor relations



Solène Kennis






1 The legal par value of one share is thus reduced from 4.00 euros to 0.045 euro and the share capital to 37,483.29 euros.

Attachment



EN
29/02/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Spineway SAS

 PRESS RELEASE

Growth of 28% of 2024 first quarter revenue

Growth of 28% of 2024 first quarter revenue Press release        Ecully, April 16, 2024 – 8 p.m. First-quarter 2024 revenue of €3.1 million Growth of 28% compared with 2023 first quarter In thousands of euros20242023Change 2023/2022Q1 revenue3,0702,398+28% Unaudited consolidated data Spineway, a specialist in innovative implants for the treatment of severe spine disorders, recorded revenue of €3.1 million in the first quarter of 2024, an increase of 28% compared with the same period in 2023. This purely organic growth (with no scope effect) reflects the Group’s strong sales momentum i...

 PRESS RELEASE

Croissance de 28% du chiffre d'affaires du 1er trimestre 2024

Croissance de 28% du chiffre d'affaires du 1er trimestre 2024 Communiqué de presse         Ecully, le 16 avril 2024 –20h Chiffre d’affaires du 1er trimestre 2024 de 3,1 M€ Progression des ventes de + 28% par rapport au 1er trimestre 2023 En milliers d’euros20242023Variation en %CA 1er trimestre3 0702 398+ 28% Données consolidées non auditées Spineway, spécialiste des implants innovants pour le traitement des pathologies sévères de la colonne vertébrale (rachis), a réalisé sur le 1er trimestre 2024 un chiffre d’affaires de 3,1 M€ en progression de 28%. Cette croissance purement organiqu...

 PRESS RELEASE

2023 Shareholders General Meeting

2023 Shareholders General Meeting Press release        Ecully, March 26, 2024 – 8.00 p.m.   Minutes of the General Meeting of March 25, 2024 The Combined General Meeting (Ordinary and Extraordinary) of Spineway shareholders was held on first notice on Monday, March 25, 2024 at 4:00 p.m. at the company’s registered office, 7 allée Moulin Berger in Ecully (69). Taking into account the representation of defaulting shareholders by SELARL TULIER POLGE ALIREZAI, as ad hoc agent appointed by Order of the President of the Commercial Court of Lyon dated March 7th, 2024, the number of shares ...

 PRESS RELEASE

Assemblée Générale 2023

Assemblée Générale 2023 Communiqué de presse         Ecully, le 26 mars 2024 – 20h   Compte-rendu de l’Assemblée Générale du 25 mars 2024 L'Assemblée Générale Mixte (Ordinaire et Extraordinaire) des actionnaires de Spineway s'est tenue sur première convocation ce lundi 25 mars 2024 à 16h au siège social de la société, 7 allée Moulin Berger à Ecully (69). Compte tenu de la représentation des actionnaires défaillants par le SELARL TULIER POLGE ALIREZAI, en qualité de mandataire ad hoc nommé par Ordonnance du Président du Tribunal de commerce de Lyon en date du 7 mars 2024, le nombre ...

 PRESS RELEASE

Reverse stock split

Reverse stock split Press release        Ecully, February 29, 2024 – 6:00 p.m. Effective date of the Spineway reverse stock split Spineway announces the completion of the reverse stock split by exchanging 1 new share of 4.00 euros par value for 2,000 old shares of 0.002 euro par value. This transaction, which was carried out pursuant to a decision by the Company's shareholders at an Extraordinary General Meeting held on November 10, 2023, took effect on February 27, 2024. The old Spineway shares with a par value of €0.002 (ISIN code: FR001400BVK2) were delisted from the Euronext Growth...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch